BofA raised the firm’s price target on UiPath (PATH) to $12 from $10 and keeps an Underperform rating on the shares. The company’s Q1 results show more stable execution, which is “welcomed after choppier results” stemming from the recent restructuring and go-to-market changes, the analyst tells investors in a research note. The firm cites stabilizing execution for the target bump but continues to have secular concerns for UiPath.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH: